<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04646382</url>
  </required_header>
  <id_info>
    <org_study_id>C003</org_study_id>
    <nct_id>NCT04646382</nct_id>
  </id_info>
  <brief_title>Effect of a Mixture of Allium Extracts on LDL Cholesterol Levels Volunteers With Elevated LDL Cholesterol Levels</brief_title>
  <official_title>Evaluation of the Effect of Consuming a Mixture of Concentrated Allium Extracts on LDL Cholesterol Levels in Healthy Volunteers With Elevated LDL Cholesterol Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DOMCA S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DOMCA S.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy of daily consumption of a combination of concentrated extracts of&#xD;
      garlic (Allium sativum L.) and onion (Allium cepa L.) on LDL cholesterol levels in healthy&#xD;
      volunteers. Parameters related to metabolic syndrome, cardiovascular health and the immune&#xD;
      system will also be analyzed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a controlled, randomized, double-blind, parallel-group nutritional intervention study.&#xD;
&#xD;
      64 healthy volunteers lwith elevated LDL cholesterol levels but who do not require&#xD;
      pharmacological treatment will be randomly distributed into 2 equal groups: control group and&#xD;
      intervention group.&#xD;
&#xD;
      For 8 weeks the volunteers will take the product immediately after lunch. During that time&#xD;
      they will maintain their lifestyle and nutritional habits.&#xD;
&#xD;
      Blood samples will be taken at 0, 2, 4 and 8 weeks. Anthropometric parameters and&#xD;
      health-related data were also measured.&#xD;
&#xD;
      Parameters related to lipid metabolism, metabolic syndrome and the immune system will be&#xD;
      analized.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 29, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Controlled, randomized, double-blind, parallel group nutritional intervention study.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Each volunteer is assigned a &quot;participant number&quot; that will be associated with a pot that will have all the product for the study.&#xD;
The &quot;pot number&quot; is the same as the &quot;participant number&quot;.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>LDL</measure>
    <time_frame>8 weeks.</time_frame>
    <description>Serum LDL cholesterol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cholesterol</measure>
    <time_frame>8 weeks</time_frame>
    <description>Serum total cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL</measure>
    <time_frame>8 weeks</time_frame>
    <description>Serum HDL cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>8 weeks</time_frame>
    <description>Serum triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>8 weeks</time_frame>
    <description>Serum glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>8 weeks</time_frame>
    <description>C-reactive protein in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidized LDL cholesterol</measure>
    <time_frame>8 weeks</time_frame>
    <description>Oxidized LDL cholesterol in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MDA</measure>
    <time_frame>8 weeks</time_frame>
    <description>Malondialdehyde in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TAC</measure>
    <time_frame>8 weeks</time_frame>
    <description>Plasma total antioxidant capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selenium</measure>
    <time_frame>8 weeks</time_frame>
    <description>Serun selenium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selenoprotein P</measure>
    <time_frame>8 weeks</time_frame>
    <description>Selenoprotein P in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VCAM-1</measure>
    <time_frame>8 weeks</time_frame>
    <description>Endothelial adhesion molecules VCAM-1 in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICAM-1</measure>
    <time_frame>8 weeks</time_frame>
    <description>Endothelial adhesion molecules ICAM-1 in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL1 beta in plasma</measure>
    <time_frame>8 weeks</time_frame>
    <description>Interleukin-1 beta in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL 6</measure>
    <time_frame>8 weeks</time_frame>
    <description>Interleukin-6 in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL 10</measure>
    <time_frame>8 weeks</time_frame>
    <description>Interleukin-10 in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>8 weeks</time_frame>
    <description>Body mass index (height/weight ratio)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abdominal perimeter</measure>
    <time_frame>8 weeks</time_frame>
    <description>Abdominal perimeter in centimeters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>8 weeks</time_frame>
    <description>Systolic pressure and diastolic pressure)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Cardiovascular Health</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Microcrystalline cellulose (9892- Capsules®) up to 400 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Garlic concentrated extract. Onion concentrated extract. Microcrystalline cellulose (9892- Capsules®) up to 400 mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Garlic and onion concentrate</intervention_name>
    <description>Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>AlioCare</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Microcrystalline cellulose</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Excipient</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  LDL-cholesterol levels between 100 and 190 mg/dL.&#xD;
&#xD;
          -  Freely agree to participate in the study and sign the informed consent document.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Be pregnant.&#xD;
&#xD;
          -  Have planned to change lifestyle and / or dietary habits.&#xD;
&#xD;
          -  Having diabetes.&#xD;
&#xD;
          -  Having a cerebrovascular disease.&#xD;
&#xD;
          -  Having a serious illness.&#xD;
&#xD;
          -  Taking products or drugs to control cholesterol levels or with antioxidant activity.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miguel Quesada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Endocrinology and Nutrition Clinic of Dr. Miguel Quesada</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juristo Fonollá, PhD</last_name>
    <phone>+34627354477</phone>
    <email>jfonolla@domca.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Domca Sau</name>
      <address>
        <city>Alhendín</city>
        <state>Granada</state>
        <zip>18620</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juristo Fonollá Joya, PhD</last_name>
      <email>jfonolla@domca.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 22, 2020</study_first_submitted>
  <study_first_submitted_qc>November 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2020</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Garlic</keyword>
  <keyword>Onion</keyword>
  <keyword>LDL cholesterol</keyword>
  <keyword>Cardiovascular health</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

